British American Tobacco enters electronic cigarette market in Britain with the 'Vype'
Monday 29 July 2013
British American Tobacco has become the first tobacco company to launch an electronic cigarette in the UK, raising fears that it could eventually boost its profits with public money should the NHS begin prescribing ecigarettes as a smoking-cessation tool.
The Medicines and Healthcare products Regulatory Agency (MHRA) announced earlier this year that it plans to regulate the products as non-prescription medicines from 2016, at which point they would be considered as a treatment option for the NHS. At present the market is dominated by smaller manufacturers who could struggle to thrive in a heavily regulated marketplace.
BAT confirmed on Monday that the firm’s new ecigarette, known as Vype, will be available to buy online from Tuesday, and will then be brought into shops from September this year.
A spokesman for the company said: “The ecigarette is currently available in a disposable format, with plans to supplement the product range with a rechargeable version.
“The development of inhaled nicotine products, which includes ecigarettes, is a natural extension of British American Tobacco’s approach to tobacco harm reduction which has been evolving over a number of years.”
Electronic cigarettes use an “eliquid” containing pharmaceutical-grade nicotine, giving users their hit of the addictive substance and providing a vapour for the smoking experience. Around 1.3 million Britons now use ecigarettes, up from 700,000 last year. But ecigarettes’ long-term effects are as yet unproven and some doctors argue their popularity could undermine anti-smoking efforts. As the market has grown established tobacco brands have moved in, including BAT, which markets Dunhill, Benson and Hedges and Lucky Strike; Imperial Tobacco, the company behind Gauloises and Davidoff, and Altria (formerly Philip Morris), which makes Marlboro and Chesterfield.
The MHRA said the market needed to be regulated because existing ecigarettes were not good enough, with contaminants found in some products and nicotine levels varying widely. Once ecigarettes are licensed, manufacturers will have to prove the quality of their products and demonstrate that they deliver the correct amount of nicotine, although they will not need to do clinical trials.
- 1 Home Office says Nigerian asylum-seeker can’t be a lesbian as she’s got children
- 2 What happens to your body when you give up sugar?
- 3 Japanese island overrun with cats after population explodes
- 4 Apple and Google users being spied on for a decade because of 'Freak' security flaw
- 5 Have sex with your iPad thanks to the new sex toy no-one asked for
The City of the Monkey God: Archaeologists claim to have found city lost for 1,000 years in remote Honduran jungle
Japanese island overrun with cats after population explodes
Delhi bus rapist blames dead victim for attack because 'girls are responsible for rape'
Bubonic plague-carrying fleas found on New York City rats
London property boom built on dirty money
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Durham Free School: 'Creationism taught at' free school facing closure
Nearly 100,000 of Britain's poorest children go hungry after parents' benefits are cut
Ukip would cut billions from Scottish budget to fund English tax cuts
End of the licence fee: BBC to back radical overhaul of how it is funded
Ukraine crisis: Top Chinese diplomat backs Putin and says West should 'abandon zero-sum mentality'
£35000 - £45000 per annum: Recruitment Genius: This distributor and wholesaler...
£26000 - £29000 per annum: Recruitment Genius: An opportunity has arisen for a...
£25000 - £35000 per annum: Recruitment Genius: This highly successful business...
£28000 - £30000 per annum + Bonus, Pension, 25days hol, PHC +: Ashdown Group: ...